| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$3,782 ) |
| | 2024 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104 | PHILADELPHIA | USA | H79TI084084 | The University of the Sciences Physician Assistant MAT Training Integration Program | 000 | 2 | SAMHSA | 10/3/2023 | $0 |
| | 2024 | 2020 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R03AG063295 | Drosophila models for tau toxicity and spreading in the central nervous system | 000 | 2 | NIH | 4/9/2024 | -$3,782 |
|
| Issue Date FY: 2023 ( Subtotal = -$460,019 ) |
| | 2023 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15CA268200 | Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment | 004 | 2 | NIH | 5/12/2023 | $20,487 |
| | 2023 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15CA268200 | Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment | 002 | 2 | NIH | 3/21/2023 | $5,732 |
| | 2023 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15CA268200 | Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment | 000 | 2 | NIH | 1/25/2023 | -$420,375 |
| | 2023 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15CA268200 | Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment | 005 | 2 | NIH | 7/10/2023 | -$12,857 |
| | 2023 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15CA268200 | Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment | 005 | 2 | NIH | 7/10/2023 | -$7,630 |
| | 2023 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R01GM138671 | Activation and Regulation Mechanisms of the RAF Kinase Family | 000 | 1 | NIH | 11/21/2022 | -$16,068 |
| | 2023 | 2020 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM140406 | Is there a common allosteric binding site for all GPCRs? | 000 | 1 | NIH | 11/13/2022 | $0 |
| | 2023 | 2020 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM139063 | Control of cell polarity and migration by non-centrosomal microtubules | 000 | 1 | NIH | 11/13/2022 | $0 |
| | 2023 | 2019 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM135933 | Characterizing the function and regulation of a conserved virulence-associated genetic pathway of pathogenic Alphaproteobacteria | 000 | 1 | NIH | 11/8/2022 | -$8,821 |
| | 2023 | 2019 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM135933 | Characterizing the function and regulation of a conserved virulence-associated genetic pathway of pathogenic Alphaproteobacteria | 004 | 1 | NIH | 5/12/2023 | $1 |
| | 2023 | 2018 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15EB026208 | Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment | 000 | 1 | NIH | 5/12/2023 | -$20,487 |
|
| Issue Date FY: 2022 ( Subtotal = $1,026,329 ) |
| | 2022 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15NS128847 | Mechanisms of mutanthuntingtin aggregate engulfment and spreading by phagocytic glia | 000 | 1 | NIH | 8/18/2022 | $427,500 |
| | 2022 | 2022 | University of the Sciences in Philadelphia | 600 S 43rd St | Philadelphia | PA | 19104-4418 | PHILADELPHIA | USA | E13HP17626 | HPSL - Pharmacy | 000 | 3 | HRSA | 7/26/2022 | $649,682 |
| | 2022 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | H79TI084084 | The University of the Sciences Physician Assistant MAT Training Integration Program | 002 | 2 | SAMHSA | 7/11/2022 | $150,000 |
| | 2022 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15CA268200 | Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment | 001 | 2 | NIH | 1/7/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15CA268200 | Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment | 000 | 2 | NIH | 12/20/2021 | $427,500 |
| | 2022 | 2022 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | H79TI084084 | The University of the Sciences Physician Assistant MAT Training Integration Program | 003 | 2 | SAMHSA | 9/27/2022 | $150,000 |
| | 2022 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R01GM138671 | Activation and Regulation Mechanisms of the RAF Kinase Family | 000 | 1 | NIH | 8/26/2022 | -$154,221 |
| | 2022 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | H79TI084084 | The University of the Sciences Physician Assistant MAT Training Integration Program | 000 | 1 | SAMHSA | 11/8/2021 | $0 |
| | 2022 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM139063 | Control of cell polarity and migration by non-centrosomal microtubules | 002 | 1 | NIH | 7/15/2022 | -$49,999 |
| | 2022 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | H79TI084084 | The University of the Sciences Physician Assistant MAT Training Integration Program | 001 | 1 | SAMHSA | 5/31/2022 | $0 |
| | 2022 | 2020 | University of the Sciences in Philadelphia | 600 S 43rd St | Philadelphia | PA | 19104-4418 | PHILADELPHIA | USA | E33HP14896 | LDS - Pharmacy | 001 | 3 | HRSA | 10/25/2021 | $0 |
| | 2022 | 2020 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R03AG063295 | Drosophila models for tau toxicity and spreading in the central nervous system | 000 | 2 | NIH | 2/24/2022 | $0 |
| | 2022 | 2020 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM140406 | Is there a common allosteric binding site for all GPCRs? | 000 | 1 | NIH | 6/30/2022 | -$224,363 |
| | 2022 | 2020 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM139063 | Control of cell polarity and migration by non-centrosomal microtubules | 000 | 1 | NIH | 6/30/2022 | -$191,680 |
| | 2022 | 2019 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM135933 | Characterizing the function and regulation of a conserved virulence-associated genetic pathway of pathogenic Alphaproteobacteria | 000 | 1 | NIH | 6/30/2022 | -$152,819 |
| | 2022 | 2018 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM128099 | Activation and Regulation Mechanisms of the RAF Kinase Family | 000 | 1 | NIH | 9/26/2022 | $0 |
| | 2022 | 2017 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | DP2DA044550 | Understanding the overlap of chromatin alteration in HIV-1 and drug abuse | 001 | 1 | NIH | 8/31/2022 | $0 |
| | 2022 | 2016 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM122033 | Development of Computer Aided Design of Helical Arylamide Foldamer Receptors for Selective Carbohydrate Recognition | 000 | 1 | NIH | 3/24/2022 | $0 |
| | 2022 | 2015 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | H79TI026008 | Screening, Brief Intervention and Referral to Treatment (SBIRT) | 000 | 1 | SAMHSA | 12/13/2021 | -$5,271 |
|
| Issue Date FY: 2021 ( Subtotal = $602,904 ) |
| | 2021 | 2021 | University of the Sciences in Philadelphia | 600 S 43rd St | Philadelphia | PA | 19104-4418 | PHILADELPHIA | USA | E1317626 | HPSL - Pharmacy | 000 | 2 | HRSA | 8/19/2021 | $78,530 |
| | 2021 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | F31CA247336 | Targeting the ER Stress Response in ARID1A-mutant Ovarian Clear Cell Carcinoma | 000 | 2 | NIH | 12/1/2020 | $45,520 |
| | 2021 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | F31CA247336 | Targeting the ER Stress Response in ARID1A-mutant Ovarian Clear Cell Carcinoma | 001 | 2 | NIH | 2/1/2021 | $516 |
| | 2021 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM139063 | Control of cell polarity and migration by non-centrosomal microtubules | 000 | 1 | NIH | 9/13/2021 | $50,000 |
| | 2021 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R01GM138671 | Activation and Regulation Mechanisms of the RAF Kinase Family | 000 | 1 | NIH | 9/10/2021 | $267,424 |
| | 2021 | 2021 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | H79TI084084 | The University of the Sciences Physician Assistant MAT Training Integration Program | 000 | 1 | SAMHSA | 9/7/2021 | $150,000 |
| | 2021 | 2021 | University of the Sciences in Philadelphia | 600 S 43rd St | Philadelphia | PA | 19104-4418 | PHILADELPHIA | USA | E3314896 | LDS - Pharmacy | 000 | 4 | HRSA | 7/12/2021 | $15,636 |
| | 2021 | 2018 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15EB026208 | Optimization of aminolevulinic acid-protoporphyrin IX for fluorescence-guided tumor resection and treatment | 000 | 1 | NIH | 5/19/2021 | $0 |
| | 2021 | 2016 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15GM122033 | Development of Computer Aided Design of Helical Arylamide Foldamer Receptors for Selective Carbohydrate Recognition | 000 | 1 | NIH | 3/8/2021 | $0 |
| | 2021 | 2016 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | F99CA212437 | HAPLN1 mediates collagen remodeling during aging to influence melanoma and immune cell motility | 000 | 1 | NIH | 2/25/2021 | -$4,722 |
| | 2021 | 2016 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | R15AR069935 | Emerin regulation of myogenic differentiation: implications for muscle disease | 000 | 1 | NIH | 6/21/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $115,127 ) (Continued on the next page) |
| | 2020 | 2020 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | F31CA247336 | Targeting the ER Stress Response in ARID1A-mutant Ovarian Clear Cell Carcinoma | 000 | 1 | NIH | 12/3/2019 | $45,016 |
| | 2020 | 2020 | UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 600 S 43RD ST | PHILADELPHIA | PA | 19104-4418 | PHILADELPHIA | USA | F31CA247336 | Targeting the ER Stress Response in ARID1A-mutant Ovarian Clear Cell Carcinoma | 001 | 1 | NIH | 12/3/2019 | $0 |
|
